ubmslateCN-logo-ubm

CN Mobile Logo

Topics:

Oncology and Hematology News and Journal Articles

Targeting PARP in Prostate Cancer: Novelty, Pitfalls, and Promise

Phillip L. Palmbos, MD, PhD, and Maha H. Hussain, MD
This article will review how PARP inhibitors function as a class, review the molecular features that sensitize cancer cells to this therapy, and discuss the data supporting its potential for patients with prostate cancer.

Recent Content

In this Medical News Minute, developed exclusively for Cancer Network, Dr. Bobby Lazzara discusses a joint effort from the American Cancer Society and IBM that aims to use the cognitive power of Watson to help cancer patients deal with their disease.

ASCO has released a clinical practice guideline on invasive cervical cancer. For the first time, ASCO created the guideline based on resource availability, tailoring recommendations to support basic- or limited-resource settings.

Adding total body irradiation to chemotherapy prior to the adoptive cell transfer of TILs had no effect on tumor regression in patients with metastatic melanoma.

A 43-year-old woman is found to have a small tumor in her left fallopian tube, and a biopsy is performed. What is your diagnosis?

A 35-year-old HIV-positive man presents with enlarged lymph nodes, and a biopsy is performed. What is your diagnosis?

A new study has identified several trends by race and ethnicity among patients with hepatocellular carcinoma (HCC) in the United States.

The accuracy of interpreting a breast cancer screening mammogram is not diminished as clinicians get toward the end of a session.

By clicking Accept, you agree to become a member of the UBM Medica Community.